Literature DB >> 26258480

Elucidation of the structure of retroviral proteases: a reminiscence.

Mariusz Jaskolski1, Maria Miller2, J K Mohana Rao2, Alla Gustchina2, Alexander Wlodawer2.   

Abstract

Determinations of only a very few protein structures had consequences comparable to the impact exerted by the structure of the protease encoded by HIV-1, published just over 25 years ago. The structure of this relatively small protein and its cousins from other retroviruses provided a clear target for a spectacularly successful structure-assisted drug design effort that offered new hope for controlling the then-escalating AIDS epidemic. This reminiscence is limited primarily to work conducted at the National Cancer Institute, and is not meant to be a comprehensive history of the field, but is rather an attempt to provide a very personal account of how the structures of this most thoroughly studied crystallographic target were determined. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  HIV; crystal structures; drug design; inhibitors; protease

Mesh:

Substances:

Year:  2015        PMID: 26258480      PMCID: PMC6310002          DOI: 10.1111/febs.13397

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  4 in total

1.  Serendipity, politics, and crystal structures, or how I became a protein crystallographer.

Authors:  Alexander Wlodawer
Journal:  Postepy Biochem       Date:  2016

Review 2.  Successes and challenges with retroviral enzymes.

Authors:  Anna Marie Skalka; Mark D Andrake; Richard A Katz
Journal:  Postepy Biochem       Date:  2016

3.  Functional Characterization of Secreted Aspartyl Proteases in Candida parapsilosis.

Authors:  Dhirendra Kumar Singh; Tibor Németh; Alexandra Papp; Renáta Tóth; Szilvia Lukácsi; Olga Heidingsfeld; Jiri Dostal; Csaba Vágvölgyi; Zsuzsa Bajtay; Mihály Józsi; Attila Gácser
Journal:  mSphere       Date:  2019-08-21       Impact factor: 4.389

4.  Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank.

Authors:  Alexander Wlodawer; Zbigniew Dauter; Ivan G Shabalin; Miroslaw Gilski; Dariusz Brzezinski; Marcin Kowiel; Wladek Minor; Bernhard Rupp; Mariusz Jaskolski
Journal:  FEBS J       Date:  2020-06-24       Impact factor: 5.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.